StreetInsider.com News Articles

Form 6-K IM Cannabis Corp. For: Jun 03

Wed, 03 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260603/26599434.html

Form 6-K IM Cannabis Corp. For: Jun 03

Wed, 03 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260603/26599434.html

IM Cannabis raises $225,000 through convertible note financing

Wed, 03 Jun 2026 16:01:41 -0400

IM Cannabis Corp. (NASDAQ: IMCC) completed a $225,000 convertible note financing through a private placement with an institutional investor, the medical cannabis company announced.

The Toronto and Israel-based company issued the note with a 10% original issuance discount under a note purchase agreement dated June 3, 2026. The note carries an 8% annual interest rate, which increases to 14% upon an event of default.

The note cannot be repaid in cash and must be satisfied through the issuance of common shares upon conversion. The conversion price is set at the lower of $0.288 per share or 90% of the lowest daily volume-weighted

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

Wed, 03 Jun 2026 16:01:00 -0400

TORONTO and GLIL YAM, Israel, June 3, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$225,000 convertible note financing in a private placement with an institutional investor (the "Lender").

Pursuant to a note purchase agreement between the Company and Lender dated June 3, 2026 (the

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

Wed, 03 Jun 2026 16:01:00 -0400

Pursuant to a note purchase agreement between the Company and Lender dated June 3, 2026 (the

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

Wed, 03 Jun 2026 16:01:00 -0400

Pursuant to a note purchase agreement between the Company and Lender dated June 3, 2026 (the

IM Cannabis Raises US$225,000 of Gross Proceeds in Convertible Note Financing

Wed, 03 Jun 2026 16:01:00 -0400

Pursuant to a note purchase agreement between the Company and Lender dated June 3, 2026 (the

IM Cannabis Corp (IMCC) Misses Q1 EPS by 38c

Wed, 13 May 2026 17:19:32 -0400

IM Cannabis Corp (NASDAQ: IMCC) reported Q1 EPS of ($0.38). Revenue for the quarter came in at $8.7 million.

For earnings history and earnings-related data on IM Cannabis Corp (IMCC) click here.

Form 6-K IM Cannabis Corp. For: May 13

Wed, 13 May 2026 16:55:00 -0400

si-local-file:///var/storage/secattach/20260513/26487195.html

Form 6-K IM Cannabis Corp. For: May 13

Wed, 13 May 2026 16:55:00 -0400

si-local-file:///var/storage/secattach/20260513/26487195.html

IM Cannabis Corp. Announces First Quarter 2026 Financial Results

Wed, 13 May 2026 16:01:00 -0400

TORONTO and GLIL YAM, Israel, May 13, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced its financial results for the first quarter ended March 31, 2026. All amounts were reported in Canadian dollars, unless otherwise stated.

IM Cannabis Corp. Announces First Quarter 2026 Financial Results

Wed, 13 May 2026 16:01:00 -0400

IM Cannabis Corp. Announces First Quarter 2026 Financial Results

Wed, 13 May 2026 16:01:00 -0400

IM Cannabis Corp. Announces First Quarter 2026 Financial Results

Wed, 13 May 2026 16:01:00 -0400

Form 6-K IM Cannabis Corp. For: May 07

Thu, 07 May 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260507/26455140.html

Form 6-K IM Cannabis Corp. For: May 07

Thu, 07 May 2026 17:09:00 -0400

si-local-file:///var/storage/secattach/20260507/26455140.html

IM Cannabis raises $550,000 through convertible note financings

Thu, 07 May 2026 16:31:05 -0400

IM Cannabis Corp. (NASDAQ: IMCC) completed convertible note financings totaling $550,000 in gross proceeds through two separate transactions with an institutional investor, according to a company statement.

The medical cannabis company, which operates in Israel and Germany, issued the first convertible note on April 6 for $250,000 with a 10% original issuance discount. The note carries an 8% annual interest rate, increasing to 14% upon default, and converts to common shares rather than cash repayment.

The first note's conversion price is set at the lower of $0.339 per share or 90% of the lowest daily volume-weighted average price during the 20 trading

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

Thu, 07 May 2026 16:30:00 -0400

TORONTO and GLIL YAM, Israel, May 7, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced the closing of a US$300,000 convertible note financing in a private placement with an institutional investor, bringing the total gross proceeds raised in recent similar financings to US$550,000.

First Note

Pursuant to a note purchase

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

Thu, 07 May 2026 16:30:00 -0400

First Note

Pursuant to a note purchase

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

Thu, 07 May 2026 16:30:00 -0400

First Note

Pursuant to a note purchase

IM Cannabis Raised US$550,000 of Gross Proceeds in Convertible Note Financings

Thu, 07 May 2026 16:30:00 -0400

First Note

Pursuant to a note purchase

Form 6-K IM Cannabis Corp. For: Apr 10

Fri, 10 Apr 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260410/26300325.html

Form 6-K IM Cannabis Corp. For: Apr 10

Fri, 10 Apr 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260410/26300325.html

IM Cannabis receives Nasdaq deficiency notice for bid price

Fri, 10 Apr 2026 16:10:33 -0400

IM Cannabis Corp. (NASDAQ: IMCC) received a notice from Nasdaq indicating the company fails to meet the minimum bid price requirement of $1.00 per share for continued listing, according to a company statement.

The medical cannabis company, which operates in Israel and Germany, has been granted 180 calendar days until October 6, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2). The company can cure the deficiency if its closing bid price reaches at least $1.00 for a minimum of ten consecutive business days during this period.

The notice does not immediately affect the company's Nasdaq listing or trading of its common

IMC Announces Receipt of Nasdaq Minimum Bid Price Notification

Fri, 10 Apr 2026 16:10:00 -0400

TORONTO and GLIL YAM, Israel, April 10, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel and Germany, today announced that it has received a written notice (the "Notice") from Nasdaq Stock Market LLC ("Nasdaq") indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.